Preparation and In Vitro/Ex Vivo Evaluation of Moxifloxacin-Loaded PLGA Nanosuspensions for Ophthalmic Application
Open Access
- 1 January 2013
- journal article
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 81 (2), 591-606
- https://doi.org/10.3797/scipharm.1204-16
Abstract
The aim of the present investigation was to prepare a colloidal ophthalmic formulation to improve the residence time of moxifloxacin. Moxifloxacin-loaded poly(dl-lactide-co-glycolide) (PLGA) nanosuspensions were prepared by using the solvent evaporation technique. The nanosuspensions were characterised physically by using different techniques like particle size, zeta potential, FTIR, DSC, and XRD analysis. In vitro and ex vivo studies of nanosuspensions were carried out using a modified USP dissolution apparatus and all-glass Franz diffusion cells, respectively. The antibacterial activities of the nanosuspension and marketed formulations were performed against S. aureus and P. aeroginosa. The moxifloxacin-loaded PLGA nanosuspensions showed uniform particle size, ranging between 164-490 nm with negative zeta potential for all batches. The percentage entrapment efficiency of the drug-loaded nano-suspension was found to be between 84.09 to 92.05%. In vitro drug release studies suggest that all of the formulations showed extended drug release profiles and follow Korsemeyer-Peppas release kinetics. In vitro corneal permeability was found to be comparable with that of the marketed formulation across isolated goat cornea, indicating the suitability of the nanosuspension formulation in the ophthalmic delivery of moxifloxacin. The optimised nano-suspension was found to be more active against S. aureus and P. aeruginosa compared to the marketed eye drops.This publication has 35 references indexed in Scilit:
- Diclofenac-loaded Eudragit S100 nanosuspension for ophthalmic deliveryJournal of Microencapsulation, 2010
- Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug deliveryNanomedicine: Nanotechnology, Biology and Medicine, 2010
- Development of mucoadhesive poly(lactide-co-glycolide) nanoparticles for ocular applicationPharmaceutical Development and Technology, 2009
- PLGA nanospheres for the ocular delivery of flurbiprofen: Drug release and interactionsJournal of Pharmaceutical Sciences, 2008
- Chitosan based nanocarriers for indomethacin ocular deliveryArchives of Pharmacal Research, 2008
- Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene.2006
- Effectiveness of Ciprofloxacin, Levofloxacin, or Moxifloxacin for Treatment of Experimental Staphylococcus aureus KeratitisAntimicrobial Agents and Chemotherapy, 2004
- Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymersJournal of Controlled Release, 2001
- Analysis of Fickian and non-Fickian drug release from polymers.1985
- Corneal Penetration Behavior of β-Blocking Agents I: Physicochemical FactorsJournal of Pharmaceutical Sciences, 1983